世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039110

オンボディインジェクター市場:規模、シェア、動向分析レポート、およびセグメント予測、2024〜2030

Grand View Research Inc.

On-body Injectors Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2024- 2030

発刊日 2024/07

言語英語

体裁PDF/130ページ

ライセンス/価格130ページ

0000039110

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

オンボディインジェクターの市場規模、シェア、動向分析レポート:技術別 (スプリングベース、モーター駆動)、用途別 (がん、糖尿病)、最終用途別、地域別、セグメント予測、2024-2030

オンボディインジェクターの市場規模と動向

世界のオンボディインジェクター市場の規模は2023年に48億ドルと推定され、2024年から2030年にかけて14.9%のCAGRで成長すると予測されます。これは、慢性疾患の有病率の増加、インジェクターの技術の進歩、在宅医療への注目の高まり、針刺しによる怪我への懸念の高まり、およびオンボディインジェクターの幅広い用途に起因しています。糖尿病、がん、喘息、アルツハイマー病、パーキンソン病などの慢性疾患は、頻繁な注射を必要とすることが多く、オンボディインジェクターは便利で管理しやすいソリューションを提供します。国際糖尿病連合 (ITF) によると、2021年には20歳から79歳までの成人5億3,700万人が糖尿病に罹患し、2030年には6億4,300万人に増加すると予想されています。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1. Segment Definitions
1.1.1. Technology
1.1.2. Application
1.1.3. End Use
1.1.4. Regional scope
1.1.5. Estimates and forecasts timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Approach 1: Commodity flow approach
1.6.3. Volume price analysis (Model 2)
1.6.4. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. Application outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. On-body Injectors Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of chronic diseases
3.2.1.2. Technological advancements
3.2.1.3. Patient preference and compliance
3.2.1.4. Increasing focus on home healthcare
3.2.1.5. Increasing concerns about needlestick injuries
3.2.2. Market Restraint Analysis
3.2.2.1. High cost compared to alternatives
3.3. On-body Injectors Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape

Chapter 4. On-body Injectors Market: Technology Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. On-body Injectors Market: Technology Movement Analysis
4.3. On-body Injectors Market by Technology Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Spring-based
4.5.1. Spring-based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Motor-driven
4.6.1. Motor-driven Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Rotary Pump
4.7.1. Rotary Pump Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Expanding Battery
4.8.1. Expanding Battery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Other
4.9.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. On-body Injectors Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. On-body Injectors Market: Application Movement Analysis
5.3. On-body Injectors Market by Application Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Oncology
5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Diabetes
5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Cardiovascular Disease
5.7.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Autoimmune Disease
5.8.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. On-body Injectors Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. On-body Injectors Market: End Use Movement Analysis
6.3. On-body Injectors Market by End Use Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. Hospitals & Clinics
6.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Home Care Settings
6.6.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. On-body Injectors Market: Regional Estimates & Trend Analysis
7.1. Regional Dashboard
7.2. Regional On-body Injectors Market movement analysis
7.3. On-body Injectors Market: Regional Estimates & Trend Analysis by Technology, Application & End Use
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5. North America
7.5.1. North America On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. U.S.
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement scenario
7.5.2.5. U.S. On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Canada
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement scenario
7.5.3.5. Canada On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Mexico
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement scenario
7.5.4.5. Mexico On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Europe
7.6.1. Europe On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. UK
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement scenario
7.6.2.5. UK On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. Germany
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement scenario
7.6.3.5. Germany On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. France
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement scenario
7.6.4.5. France On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. Italy
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement scenario
7.6.5.5. Italy On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.6. Spain
7.6.6.1. Key Country Dynamics
7.6.6.2. Competitive Scenario
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement scenario
7.6.6.5. Spain On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.7. Denmark
7.6.7.1. Key Country Dynamics
7.6.7.2. Competitive Scenario
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement scenario
7.6.7.5. Denmark On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.8. Sweden
7.6.8.1. Key Country Dynamics
7.6.8.2. Competitive Scenario
7.6.8.3. Regulatory Framework
7.6.8.4. Reimbursement scenario
7.6.8.5. Sweden On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.9. Norway
7.6.9.1. Key Country Dynamics
7.6.9.2. Competitive Scenario
7.6.9.3. Regulatory Framework
7.6.9.4. Reimbursement scenario
7.6.9.5. Norway On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Asia Pacific On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.2. Japan
7.7.2.1. Key Country Dynamics
7.7.2.2. Competitive Scenario
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement scenario
7.7.2.5. Japan On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.3. China
7.7.3.1. Key Country Dynamics
7.7.3.2. Competitive Scenario
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement scenario
7.7.3.5. China On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.4. India
7.7.4.1. Key Country Dynamics
7.7.4.2. Competitive Scenario
7.7.4.3. Regulatory Framework
7.7.4.4. Reimbursement scenario
7.7.4.5. India On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. Key Country Dynamics
7.7.5.2. Competitive Scenario
7.7.5.3. Regulatory Framework
7.7.5.4. Reimbursement scenario
7.7.5.5. South Korea On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.6. Australia
7.7.6.1. Key Country Dynamics
7.7.6.2. Competitive Scenario
7.7.6.3. Regulatory Framework
7.7.6.4. Reimbursement scenario
7.7.6.5. Australia On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7.7. Thailand
7.7.7.1. Key Country Dynamics
7.7.7.2. Competitive Scenario
7.7.7.3. Regulatory Framework
7.7.7.4. Reimbursement scenario
7.7.7.5. Thailand On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Latin America
7.8.1. Latin America On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.2. Brazil
7.8.2.1. Key Country Dynamics
7.8.2.2. Competitive Scenario
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement scenario
7.8.2.5. Brazil On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key Country Dynamics
7.8.3.2. Competitive Scenario
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement scenario
7.8.3.5. Argentina On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Middle East & Africa
7.9.1. Middle East & Africa On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.2. South Africa
7.9.2.1. Key Country Dynamics
7.9.2.2. Competitive Scenario
7.9.2.3. Regulatory Framework
7.9.2.4. Reimbursement scenario
7.9.2.5. South Africa On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.3. Saudi Arabia
7.9.3.1. Key Country Dynamics
7.9.3.2. Competitive Scenario
7.9.3.3. Regulatory Framework
7.9.3.4. Reimbursement scenario
7.9.3.5. Saudi Arabia On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.4. UAE
7.9.4.1. Key Country Dynamics
7.9.4.2. Competitive Scenario
7.9.4.3. Regulatory Framework
7.9.4.4. Reimbursement scenario
7.9.4.5. UAE On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9.5. Kuwait
7.9.5.1. Key Country Dynamics
7.9.5.2. Competitive Scenario
7.9.5.3. Regulatory Framework
7.9.5.4. Reimbursement scenario
7.9.5.5. Kuwait On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Key Company Profiles
8.2.1. West Pharmaceutical Services, Inc.
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. BD
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Stevanato Group
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Enable Injections
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Nemera
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Debiotech SA
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. AbbVie, Inc.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Coherus BioSciences, Inc.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Gerresheimer AG
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. E3D Elcam Drug Delivery Devices
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 4 Global on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 5 Global on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 6 North America on-body injectors market, by region, 2018 - 2030 (USD Million)
Table 7 North America on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 8 North America on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 9 North America on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 11 U.S. on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 14 Canada on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 15 Canada on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 16 Mexico on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 17 Mexico on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 18 Mexico on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 19 Europe on-body injectors market, by country, 2018 - 2030 (USD Million)
Table 20 Europe on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 21 Europe on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 22 Europe on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 23 UK on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 24 UK on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 25 UK on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 26 Germany on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 27 Germany on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 28 Germany on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 29 France on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 30 France on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 31 France on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 32 Italy on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 33 Italy on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 34 Italy on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 35 Spain on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 36 Spain on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 37 Spain on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 38 Norway on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 39 Norway on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 40 Norway on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 41 Sweden on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 42 Sweden on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 43 Sweden on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 44 Denmark on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 45 Denmark on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 46 Denmark on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 47 Asia Pacific on-body injectors market, by country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 49 Asia Pacific on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 50 Asia Pacific on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 51 Japan on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 52 Japan on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 53 Japan on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 54 China on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 55 China on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 56 China on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 57 India on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 58 India on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 59 India on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 60 Australia on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 61 Australia on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 62 Australia on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 63 South Korea on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 64 South Korea on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 65 South Korea on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 66 Thailand on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 67 Thailand on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 68 Thailand on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 69 Latin America on-body injectors market, by country, 2018 - 2030 (USD Million)
Table 70 Latin America on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 71 Latin America on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 72 Latin America on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 73 Brazil on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 74 Brazil on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 75 Brazil on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 76 Argentina on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 77 Argentina on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 78 Argentina on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 79 Middle East & Africa on-body injectors market, by country, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 83 South Africa on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 84 South Africa on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 85 South Africa on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 89 UAE on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 90 UAE on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 91 UAE on-body injectors market, by end use, 2018 - 2030 (USD Million)
Table 92 Kuwait on-body injectors market, by technology, 2018 - 2030 (USD Million)
Table 93 Kuwait on-body injectors market, by application, 2018 - 2030 (USD Million)
Table 94 Kuwait on-body injectors market, by end use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 On-body injectors market segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 On-body injectors market, technology outlook key takeaways (USD Million)
Fig. 12 On-body injectors market: Technology movement analysis (USD Million), 2023 & 2030
Fig. 13 Spring-based market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Motor-driven market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Rotary pump market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Expanding battery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Other market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 On-body injectors market, application outlook key takeaways (USD Million)
Fig. 19 On-body injectors market: Application movement analysis (USD Million), 2023 & 2030
Fig. 20 Oncology market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Diabetes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Cardiovascular disease market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Autoimmune disease market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 On-body injectors market, end use outlook key takeaways (USD Million)
Fig. 26 On-body injectors market: End use movement analysis (USD Million), 2023 & 2030
Fig. 27 Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Home care settings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 On-body injectors market: Regional key takeaways (USD Million)
Fig. 31 On-body injectors market: Regional outlook, 2023 & 2030, USD Million
Fig. 32 North America on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 U.S. on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Canada on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Mexico on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Europe on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 UK on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Germany on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 France on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Spain on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Italy on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Sweden on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Norway on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Denmark on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Asia Pacific on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 China on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Japan on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 India on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 South Korea on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Australia on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Thailand on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Latin America on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Brazil on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Argentina on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Middle East and Africa on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 South Africa on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Saudi Arabia on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 UAE on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Kuwait on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 List of key emerging company’s/technology disruptors/innovators

この商品のレポートナンバー

0000039110

TOP